Home > Merus Labs
To be the Pan-European and Canadian leader in small and mid-sized specialty medicines by being nimble and entrepreneurial.
The Merus Labs strategy is driven by an entrepreneurial spirit, coupled with a highly disciplined approach. This allows Merus Labs to acquire and optimize legacy pharmaceuticals and new specialty medicines in a number of therapeutic categories.
Merus Labs has a specific focus on Europe, where we have built a strong pan-European platform, covering the full continent. As well, Merus Labs sells products in four countries outside Europe, including Canada, Australia, South Korea and Mexico.